Skip to content

Focal Cortical Dysplasias and Epilepsy: Characteristics of Histopathology and 7 tesla MRI.

Focal Cortical Dysplasias and Epilepsy: Characteristics of Histopathology and 7 tesla MRI. - CODE 7

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44372
Enrollment
80
Registered
2015-04-14
Start date
2015-08-18
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy epileptic seizures

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. All patients selected by the Dutch Collaborative Epilepsy Surgery Program board for the diagnostic work-up for the surgical treatment of refractory epilepsy and a suspected malformation of cortical development or cortical dysplasia as underlying cause, with and without presence of primary lesion (mesiotemporal sclerosis, glioneuronal tumor, vascular malformation or traumatic brain injury at young age). Also, in case of suspicion of focal epilepsy and negative clinical (3T) MRI 2. Prior clinical 1.5 or 3T MRI

Exclusion criteria

Exclusion criteria: 1. Age under 6 2. Mentally or physically incapable of giving consent (for age 12 years and up) 3.Insufficient understanding of Dutch written or spoken patient information (parent or legal guardian for patients under 12, both patient and parent or legal guardian for patients in the age 12-18) 4. Uncooperative during previous MRI scans 5. Contra-indications for 7 T MRI as specified by the UMCU radiology department at the time of inclusion.

Design outcomes

Primary

MeasureTime frame
• Presence on 7T MRI and lower-field MRI of specific characteristics of FCD. Comparison of imaging characteristics on 3 and 7 T MRI. • Correlates between in-vivo and ex-vivo 7 T MRI characteristics and histopathological findings and quantifications in resected dysplastic tissues. • Histopathological diagnosis

Secondary

MeasureTime frame
• Seizure outcome • Seizure frequency • Semiology • Age of seizure onset • Abnormalities on PET • Abnormalities on SPECT • Abnormalities on MEG • Abnormalities on EEG • Abnormalities on Electrocorticography

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)